Insider · CIK 0001967168

Kintz Samuel

CIK 0001967168 Name as filed on the most recent filing

Filed as Kintz Samuel (33)

52 transaction lines · from 33 filings · filed 2023-09-26 to 2025-11-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

52 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-11-17 S, Open-market sale Enliven Therapeutics, Inc.ELVN 272,739, disposed Open Form 4 filing 0001967168-25-000008
2025-10-17 S, Open-market sale Enliven Therapeutics, Inc.ELVN 266,654, disposed Open Form 4 filing 0001967168-25-000007
2025-09-26 S, Open-market sale Enliven Therapeutics, Inc.ELVN 74,228, disposed Open Form 4 filing 0001967168-25-000006
2025-09-23 S, Open-market sale Enliven Therapeutics, Inc.ELVN 56,084, disposed Open Form 4 filing 0001967168-25-000005
2025-09-19 S, Open-market sale Enliven Therapeutics, Inc.ELVN 20,250, disposed Open Form 4 filing 0001967168-25-000004
2025-09-17 S, Open-market sale Enliven Therapeutics, Inc.ELVN 95,473, disposed Open Form 4 filing 0001967168-25-000004
2025-08-20 S, Open-market sale Enliven Therapeutics, Inc.ELVN 30,343, disposed Open Form 4 filing 0001415889-25-022649
2025-08-19 S, Open-market sale Enliven Therapeutics, Inc.ELVN 11,800, disposed Open Form 4 filing 0001415889-25-022459
2025-08-18 S, Open-market sale Enliven Therapeutics, Inc.ELVN 208,106, disposed Open Form 4 filing 0001415889-25-022459
2025-07-17 S, Open-market sale Enliven Therapeutics, Inc.ELVN 3 lines 281,518, disposed Open Form 4 filing 0001415889-25-020087
2025-06-17 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 277,292, disposed Open Form 4 filing 0001415889-25-017730
2025-06-03 S, Open-market sale Enliven Therapeutics, Inc.ELVN 150,352, disposed Open Form 4 filing 0001415889-25-015785
2025-05-19 S, Open-market sale Enliven Therapeutics, Inc.ELVN 82,453, disposed Open Form 4 filing 0001415889-25-013992
2025-05-02 S, Open-market sale Enliven Therapeutics, Inc.ELVN 43,409, disposed Open Form 4 filing 0001415889-25-012030
2025-05-01 S, Open-market sale Enliven Therapeutics, Inc.ELVN 107,007, disposed Open Form 4 filing 0001415889-25-012030
2025-04-17 S, Open-market sale Enliven Therapeutics, Inc.ELVN 82,096, disposed Open Form 4 filing 0001415889-25-011121
2025-03-17 S, Open-market sale Enliven Therapeutics, Inc.ELVN 260,320, disposed Open Form 4 filing 0001415889-25-008609
2024-10-18 S, Open-market sale Enliven Therapeutics, Inc.ELVN 27,723, disposed Open Form 4 filing 0001415889-24-025503
2024-10-09 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 470,405, disposed Open Form 4 filing 0001415889-24-024991
2024-10-08 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 370,929, disposed Open Form 4 filing 0001415889-24-024991
2024-10-07 S, Open-market sale Enliven Therapeutics, Inc.ELVN 75,075, disposed Open Form 4 filing 0001415889-24-024901
2024-10-04 S, Open-market sale Enliven Therapeutics, Inc.ELVN 335,792, disposed Open Form 4 filing 0001415889-24-024901
2024-10-01 S, Open-market sale Enliven Therapeutics, Inc.ELVN 14,485, disposed Open Form 4 filing 0001415889-24-024671
2024-08-26 S, Open-market sale Enliven Therapeutics, Inc.ELVN 274,718, disposed Open Form 4 filing 0001415889-24-022512
2024-07-31 S, Open-market sale Enliven Therapeutics, Inc.ELVN 62,555, disposed Open Form 4 filing 0001415889-24-020687
2024-07-25 S, Open-market sale Enliven Therapeutics, Inc.ELVN 3 lines 299,073, disposed Open Form 4 filing 0001415889-24-020265
2024-06-25 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 259,902, disposed Open Form 4 filing 0001415889-24-018336
2024-05-28 S, Open-market sale Enliven Therapeutics, Inc.ELVN 3 lines 278,210, disposed Open Form 4 filing 0001415889-24-014915
2024-04-25 S, Open-market sale Enliven Therapeutics, Inc.ELVN 202,700, disposed Open Form 4 filing 0001415889-24-011707
2024-04-11 S, Open-market sale Enliven Therapeutics, Inc.ELVN 1,194,700, disposed Open Form 4 filing 0001415889-24-010828
2024-03-25 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 210,661, disposed Open Form 4 filing 0001415889-24-009220
2024-02-26 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 202,653, disposed Open Form 4 filing 0001415889-24-005748
2024-01-25 S, Open-market sale Enliven Therapeutics, Inc.ELVN 2 lines 188,229, disposed Open Form 4 filing 0001209191-24-002392
2023-12-26 S, Open-market sale Enliven Therapeutics, Inc.ELVN 175,709, disposed Open Form 4 filing 0001209191-23-059908
2023-12-22 S, Open-market sale Enliven Therapeutics, Inc.ELVN 106,655, disposed Open Form 4 filing 0001209191-23-059717
2023-12-21 S, Open-market sale Enliven Therapeutics, Inc.ELVN 260, disposed Open Form 4 filing 0001209191-23-059717
2023-12-20 S, Open-market sale Enliven Therapeutics, Inc.ELVN 101,238, disposed Open Form 4 filing 0001209191-23-059433

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 52
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Kintz Samuel, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001967168

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.